BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:PhD defence T.E. König
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260416T134500
DTEND:20260416T151500
DTSTAMP:20260416T134500
UID:phd-defence-t-e-konig@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260827T000735
LOCATION:Main building VU, 1105, Aula, De Boelelaan, 1081 HV, Amsterdam
SUMMARY:PhD defence T.E. König
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p><p>Ovarian responsivene
 ss to gonadotropins</p></p> <p>A central theme emerging from this the
 sis is that ovarian ageing and ovarian responsiveness are the result 
 of a complex interplay between follicle quantity, oocyte quality, end
 ocrine regulation, and genetic variation. While ovarian reserve tests
  inform expectations regarding stimulation outcomes, they do not sole
 ly determine reproductive potential. Similarly, although genetic vari
 ants in FSHR modulate ovarian sensitivity, they do not significantly 
 influence live birth outcomes nor justify routine dose escalation. Th
 e studies presented in this thesis further demonstrate that diminishe
 d ovarian reserve does not equate to a lack of functional ovarian res
 ponsiveness. Overall, the findings support a cautious, individualized
 , and evidence-based approach to ovarian stimulation, in which age, o
 varian reserve, and biological variability are jointly considered, ra
 ther than relying on single biomarkers or empiric dose escalation.</p
 ><p>More information on the <a href="https://hdl.handle.net/1871.1/45
 d37537-db7c-4a91-89e3-cf58e248870b" data-new-window="true" target="_b
 lank" rel="noopener noreferrer">thesis</a></p> </body> </html>
DESCRIPTION: Ovarian responsiveness to gonadotropins A central theme e
 merging from this thesis is that ovarian ageing and ovarian responsiv
 eness are the result of a complex interplay between follicle quantity
 , oocyte quality, endocrine regulation, and genetic variation. While 
 ovarian reserve tests inform expectations regarding stimulation outco
 mes, they do not solely determine reproductive potential. Similarly, 
 although genetic variants in FSHR modulate ovarian sensitivity, they 
 do not significantly influence live birth outcomes nor justify routin
 e dose escalation. The studies presented in this thesis further demon
 strate that diminished ovarian reserve does not equate to a lack of f
 unctional ovarian responsiveness. Overall, the findings support a cau
 tious, individualized, and evidence-based approach to ovarian stimula
 tion, in which age, ovarian reserve, and biological variability are j
 ointly considered, rather than relying on single biomarkers or empiri
 c dose escalation.More information on the <a href="https://hdl.handle
 .net/1871.1/45d37537-db7c-4a91-89e3-cf58e248870b" data-new-window="tr
 ue" target="_blank" rel="noopener noreferrer">thesis</a>
END:VEVENT
END:VCALENDAR
